1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF497 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA TXNDC16 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA LEF1 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA THAP8 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA KIAA1958 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA KCNB2 CTRPv2 pan-cancer AAC 0.16 2e-07
mRNA SHCBP1 CTRPv2 pan-cancer AAC -0.17 2e-07
mRNA FUZ CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA ST8SIA3 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA CTD-3105H18.18 CTRPv2 pan-cancer AAC 0.17 2e-07
Download CSV